Obesity, metabolic syndrome, and airway disease: A bioenergetic problem?

Immunology and Allergy Clinics of North America

Volumn 34, Issue 4, 2014, Pages 785-796

  Agrawal, Anurag ^a   Prakash, Y S ^b,c  

^a CSIR INSTITUTE OF GENOMICS AND INTEGRATIVE BIOLOGY   (India)

^b MAYO CLINIC   (United States)

^c MAYO GRADUATE SCHOOL   (United States)

Author keywords

Arginine; Asthma; Bioenergetics; Metabolic syndrome; Metformin; Mitochondria; Reactive oxygen species; Statin

Indexed keywords

ANTIOXIDANT; LIPOXYGENASE; METFORMIN; MITOQ; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; UBIDECARENONE; UNCLASSIFIED DRUG; 10-(6'-UBIQUINONYL)DECYLTRIPHENYLPHOSPHONIUM BROMIDE; ORGANOPHOSPHORUS COMPOUND; UBIQUINONE;

AEROBIC EXERCISE; ASTHMA; BIOENERGY; BIOGENESIS; CALORIC RESTRICTION; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE SEVERITY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; HUMAN; INSULIN RESISTANCE; LIFESTYLE MODIFICATION; MESENCHYMAL STEM CELL TRANSPLANTATION; METABOLIC SYNDROME X; NONHUMAN; OBESITY; PATHOPHYSIOLOGY; REVIEW; RISK FACTOR; SEDENTARY LIFESTYLE; ANALOGS AND DERIVATIVES; BRONCHIAL HYPERREACTIVITY; DRUG EFFECTS; EMBRYOLOGY; ENERGY METABOLISM; EXERCISE; METABOLISM; MITOCHONDRION; MOLECULARLY TARGETED THERAPY;

ASTHMA; BRONCHIAL HYPERREACTIVITY; CALORIC RESTRICTION; ENERGY METABOLISM; EXERCISE; HUMANS; METABOLIC SYNDROME X; MITOCHONDRIA; MOLECULAR TARGETED THERAPY; OBESITY; ORGANOPHOSPHORUS COMPOUNDS; UBIQUINONE;

EID: 84922330185     PISSN: 08898561     EISSN: 15578607     Source Type: Journal    
DOI: 10.1016/j.iac.2014.07.004     Document Type: Review

References (73)

1. Kent B.D., Lane S.J. Twin epidemics: asthma and obesity. Int Arch Allergy Immunol 2012, 157:213-214.
2. Brisbon N., Plumb J., Brawer R., et al. The asthma and obesity epidemics: the role played by the built environment-a public health perspective. JAllergy Clin Immunol 2005, 115:1024-1028.
3. Beuther D.A. Recent insight into obesity and asthma. Curr Opin Pulm Med 2010, 16:64-70.
4. Farzan S. The asthma phenotype in the obese: distinct or otherwise?. JAllergy (Cairo) 2013, 2013:602908.
5. Agrawal A., Sood A., Linneberg A., et al. Mechanistic understanding of the effect of obesity on asthma and allergy. JAllergy (Cairo) 2013, 2013:598904.
6. Agrawal A., Mabalirajan U., Ahmad T., et al. Emerging interface between metabolic syndrome and asthma. Am J Respir Cell Mol Biol 2011, 44(3):270-275.
7. Ahmad T., Mukherjee S., Pattnaik B., et al. Miro1 regulates intercellular mitochondrial transport & enhances mesenchymal stem cell rescue efficacy. EMBO J 2014, 33(9):994-1010.
8. Hill B.G., Benavides G.A., Lancaster J.R., et al. Integration of cellular bioenergetics with mitochondrial quality control and autophagy. Biol Chem 2012, 393:1485-1512.
9. Aravamudan B., Thompson M.A., Pabelick C.M., et al. Mitochondria in lung diseases. Expert Rev Respir Med 2013, 7:631-646.
10. Lee H.K., Park K.S., Cho Y.M., et al. Mitochondria-based model for fetal origin of adult disease and insulin resistance. Ann N Y Acad Sci 2005, 1042:1-18.
11. Irving B.A., Nair K.S. Aging and diabetes: mitochondrial dysfunction. Curr Diab Rep 2007, 7:249-251.
12. Vernochet C., Kahn C.R. Mitochondria, obesity and aging. Aging (Albany NY) 2012, 4:859-860.
13. Martin S.D., McGee S.L. The role of mitochondria in the aetiology of insulin resistance and type 2 diabetes. Biochim Biophys Acta 2014, 1840:1303-1312.
14. Aravamudan B., Kiel A., Freeman M., et al. Cigarette smoke-induced mitochondrial fragmentation and dysfunction in human airway smooth muscle. Am J Physiol Lung Cell Mol Physiol 2014, 306(9):L840-L854.
15. Naviaux R.K. Metabolic features of the cell danger response. Mitochondrion 2013, 16:7-17.
16. Mabalirajan U., Ghosh B. Mitochondrial dysfunction in metabolic syndrome and asthma. JAllergy (Cairo) 2013, 2013:340476.
17. Farid S., Mirshafiey A., Razavi A. Siglec-8 and Siglec-F, the new therapeutic targets in asthma. Immunopharmacol Immunotoxicol 2012, 34:721-726.
18. Roscioli E., Hamon R., Ruffin R.E., et al. Cellular inhibitor of apoptosis-2 is a critical regulator of apoptosis in airway epithelial cells treated with asthma-related inflammatory cytokines. Physiol Rep 2013, 1:e00123.
19. Cheng Z., Ristow M. Mitochondria and metabolic homeostasis. Antioxid Redox Signal 2013, 19:240-242.
20. Lanza I.R., Short D.K., Short K.R., et al. Endurance exercise as a countermeasure for aging. Diabetes 2008, 57:2933-2942.
21. Jelenik T., Roden M. Mitochondrial plasticity in obesity and diabetes mellitus. Antioxid Redox Signal 2013, 19:258-268.
22. Martin-Montalvo A., de Cabo R. Mitochondrial metabolic reprogramming induced by calorie restriction. Antioxid Redox Signal 2013, 19:310-320.
23. Cheng Z., Almeida F.A. Mitochondrial alteration in type 2 diabetes and obesity: an epigenetic link. Cell Cycle 2014, 13:890-897.
24. Hancock C.R., Han D.H., Chen M., et al. High-fat diets cause insulin resistance despite an increase in muscle mitochondria. Proc Natl Acad Sci USA 2008, 105:7815-7820.
25. Watt M.J., Hevener A.L. Fluxing the mitochondria to insulin resistance. Cell Metab 2008, 7:5-6.
26. Singh S., Prakash Y.S., Linneberg A., et al. Insulin and the lung: connecting asthma and metabolic syndrome. JAllergy (Cairo) 2013, 2013:627384.
27. Nie Z., Jacoby D.B., Fryer A.D. Hyperinsulinemia potentiates airway responsiveness to parasympathetic nerve stimulation in obese rats. Am J Respir Cell Mol Biol 2014, 51(2):251-261.
28. Palmieri V.O., De Rasmo D., Signorile A., et al. T16189C mitochondrial DNA variant is associated with metabolic syndrome in Caucasian subjects. Nutrition 2011, 27:773-777.
29. Gemma C., Sookoian S., Dieuzeide G., et al. Methylation of TFAM gene promoter in peripheral white blood cells is associated with insulin resistance in adolescents. Mol Genet Metab 2010, 100:83-87.
30. Gianotti T.F., Sookoian S., Dieuzeide G., et al. Adecreased mitochondrial DNA content is related to insulin resistance in adolescents. Obesity (Silver Spring) 2008, 16:1591-1595.
31. Konradova V., Copova C., Sukova B., et al. Ultrastructure of the bronchial epithelium in three children with asthma. Pediatr Pulmonol 1985, 1:182-187.
32. Mabalirajan U., Dinda A.K., Kumar S., et al. Mitochondrial structural changes and dysfunction are associated with experimental allergic asthma. JImmunol 2008, 181:3540-3548.
33. Mabalirajan U., Rehman R., Ahmad T., et al. 12/15-lipoxygenase expressed in non-epithelial cells causes airway epithelial injury in asthma. Sci Rep 2013, 3:1540.
34. Rehman R., Bhat Y.A., Panda L., et al. TRPV1 inhibition attenuates IL-13 mediated asthma features in mice by reducing airway epithelial injury. Int Immunopharmacol 2013, 15:597-605.
35. Mabalirajan U., Rehman R., Ahmad T., et al. Linoleic acid metabolite drives severe asthma by causing airway epithelial injury. Sci Rep 2013, 3:1349.
36. Mabalirajan U., Ahmad T., Leishangthem G.D., et al. L-arginine reduces mitochondrial dysfunction and airway injury in murine allergic airway inflammation. Int Immunopharmacol 2010, 10:1514-1519.
37. Ahmad T., Mabalirajan U., Ghosh B., et al. Altered asymmetric dimethyl arginine metabolism in allergically inflamed mouse lungs. Am J Respir Cell Mol Biol 2010, 42:3-8.
38. Aguilera-Aguirre L., Bacsi A., Saavedra-Molina A., et al. Mitochondrial dysfunction increases allergic airway inflammation. JImmunol 2009, 183:5379-5387.
39. Flaquer A., Heinzmann A., Rospleszcz S., et al. Association study of mitochondrial genetic polymorphisms in asthmatic children. Mitochondrion 2014, 14:49-53.
40. Litonjua A.A., Carey V.J., Burge H.A., et al. Parental history and the risk for childhood asthma. Does mother confer more risk than father?. Am J Respir Crit Care Med 1998, 158:176-181.
41. Schauberger E.M., Ewart S.L., Arshad S.H., et al. Identification of ATPAF1 as a novel candidate gene for asthma in children. JAllergy Clin Immunol 2011, 128:753-760.e11.
42. Zifa E., Daniil Z., Skoumi E., et al. Mitochondrial genetic background plays a role in increasing risk to asthma. Mol Biol Rep 2012, 39:4697-4708.
43. Ahmad T., Aggarwal K., Pattnaik B., et al. Computational classification of mitochondrial shapes reflects stress and redox state. Cell Death Dis 2013, 4:e461.
44. Leishangthem G.D., Mabalirajan U., Singh V.P., et al. Ultrastructural changes of airway in murine models of allergy and diet-induced metabolic syndrome. ISRN Allergy 2013, 2013:261297.
45. Agarwal A.R., Yin F., Cadenas E. Short-term cigarette smoke exposure leads to metabolic alterations in lung alveolar cells. Am J Respir Cell Mol Biol 2014, 51(2):284-293.
46. Hoffmann R.F., Zarrintan S., Brandenburg S.M., et al. Prolonged cigarette smoke exposure alters mitochondrial structure and function in airway epithelial cells. Respir Res 2013, 14:97.
47. Puente-Maestu L., Perez-Parra J., Godoy R., et al. Abnormal transition pore kinetics and cytochrome C release in muscle mitochondria of patients with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 2009, 40:746-750.
48. Ito K., Colley T., Mercado N. Geroprotectors as a novel therapeutic strategy for COPD, an accelerating aging disease. Int J Chron Obstruct Pulmon Dis 2012, 7:641-652.
49. Ito K., Barnes P.J. COPD as a disease of accelerated lung aging. Chest 2009, 135:173-180.
50. MacNee W. Accelerated lung aging: a novel pathogenic mechanism of chronic obstructive pulmonary disease (COPD). Biochem Soc Trans 2009, 37:819-823.
51. Hoeks J., Schrauwen P. Muscle mitochondria and insulin resistance: a human perspective. Trends Endocrinol Metab 2012, 23:444-450.
52. Lanza I.R., Nair K.S. Muscle mitochondrial changes with aging and exercise. Am J Clin Nutr 2009, 89:467S-471S.
53. Martin-Montalvo A., Mercken E.M., Mitchell S.J., et al. Metformin improves healthspan and lifespan in mice. Nat Commun 2013, 4:2192.
54. Golay A. Metformin and body weight. Int J Obes (Lond) 2008, 32:61-72.
55. Calixto M.C., Lintomen L., Andre D.M., et al. Metformin attenuates the exacerbation of the allergic eosinophilic inflammation in high fat-diet-induced obesity in mice. PLoS One 2013, 8:e76786.
56. Park C.S., Bang B.R., Kwon H.S., et al. Metformin reduces airway inflammation and remodeling via activation of AMP-activated protein kinase. Biochem Pharmacol 2012, 84:1660-1670.
57. Shore S.A., Williams E.S., Zhu M. No effect of metformin on the innate airway hyperresponsiveness and increased responses to ozone observed in obese mice. JAppl Physiol (1985) 2008, 105:1127-1133.
58. Mabalirajan U., Ahmad T., Leishangthem G.D., et al. Beneficial effects of high dose of L-arginine on airway hyperresponsiveness and airway inflammation in a murine model of asthma. JAllergy Clin Immunol 2010, 125:626-635.
59. Mabalirajan U., Aich J., Agrawal A., et al. Mepacrine inhibits subepithelial fibrosis by reducing the expression of arginase and TGF-beta1 in an extended subacute mouse model of allergic asthma. Am J Physiol Lung Cell Mol Physiol 2009, 297:L411-L419.
60. Ahmad T., Mabalirajan U., Sharma A., et al. Simvastatin improves epithelial dysfunction and airway hyperresponsiveness: from ADMA to asthma. Am J Respir Cell Mol Biol 2010, 44(4):531-539.
61. Mabalirajan U., Ahmad T., Rehman R., et al. Baicalein reduces airway injury in allergen and IL-13 induced airway inflammation. PLoS One 2013, 8:e62916.
62. Aich J., Mabalirajan U., Ahmad T., et al. Resveratrol attenuates experimental allergic asthma in mice by restoring inositol polyphosphate 4 phosphatase (INPP4A). Int Immunopharmacol 2012, 14:438-443.
63. Mabalirajan U., Aich J., Leishangthem G.D., et al. Effects of vitamin E on mitochondrial dysfunction and asthma features in an experimental allergic murine model. JAppl Physiol (1985) 2009, 107:1285-1292.
64. Mabalirajan U., Dinda A.K., Sharma S.K., et al. Esculetin restores mitochondrial dysfunction and reduces allergic asthma features in experimental murine model. JImmunol 2009, 183:2059-2067.
65. Madmani M.E., Solaiman A.Y., Tamr Agha K., et al. Coenzyme Q10 for heart failure. Cochrane Database Syst Rev 2013, (9). CD008684.
66. Gazdik F., Gvozdjakova A., Horvathova M., et al. Levels of coenzyme Q10 in asthmatics. Bratisl Lek Listy 2002, 103:353-356.
67. Gvozdjakova A., Kucharska J., Bartkovjakova M., et al. Coenzyme Q10 supplementation reduces corticosteroids dosage in patients with bronchial asthma. Biofactors 2005, 25:235-240.
68. Littarru G.P., Tiano L. Clinical aspects of coenzyme Q10: an update. Nutrition 2010, 26:250-254.
69. Gomez-Cabrera M.C., Domenech E., Romagnoli M., et al. Oral administration of vitamin C decreases muscle mitochondrial biogenesis and hampers training-induced adaptations in endurance performance. Am J Clin Nutr 2008, 87:142-149.
70. Armstrong J.S. Mitochondria-directed therapeutics. Antioxid Redox Signal 2008, 10:575-578.
71. Barbi J., Pardoll D., Pan F. Metabolic control of the Treg/Th17 axis. Immunol Rev 2013, 252:52-77.
72. Cottrell L., Neal W.A., Ice C., et al. Metabolic abnormalities in children with asthma. Am J Respir Crit Care Med 2011, 183:441-448.
73. Islam M.N., Das S.R., Emin M.T., et al. Mitochondrial transfer from bone-marrow-derived stromal cells to pulmonary alveoli protects against acute lung injury. Nat Med 2012, 18:759-765.